TRex Bio Files for Nasdaq IPO
MT newswire2026/10/05 14:0610:06 AM EDT, 10/05/2026 (MT Newswires) -- TRex Bio has filed a preliminary prospectus for an initial public offering of about 8.3 million common shares expected to be priced between $14 and $16 apiece, according to a filing with the US Securities and Exchange Commission Monday. TRex Bio said Eli Lilly (LLY) has indicated an interest buying shares of the company during the IPO, and that Eli Lilly's stake will not exceed 19.9% when combined with the shares it already owns. Underwriters were granted an option for a period of 30 days to purchase up to 1.25 million additional shares, TRex Bio said. The clinical-stage biopharmaceutical company said it expects net proceeds of about $111.3 million, which will be used to advance the clinical development of TRB-061 and TRB-071 as well as for working capital and general corporate purposes. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol "TRXB," the filing showed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.
Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Europe Becomes a Safe Haven Amid AI Turbulence! Citi Turns Bullish on European Stocks, Downgrades US Stocks: Low AI Exposure Seen as Key Advantage
Citigroup strategists have downgraded the rating of U.S. stocks and upgraded the rating of European stocks, following the recent market turbulence caused by upheaval in the artificial intelligence industry.
Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned
According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.
Crypto prices
More
